Total Payments
$2,441
2024 Payments
$628.79
Companies
10
Transactions
45
Medicare Patients
10,054
Medicare Billing
$654,772
Payment Breakdown by Category
Food & Beverage$2,441 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,441 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $536.49 | 5 | $0 (2024) |
| BIOTRONIK INC. | $434.83 | 4 | $0 (2019) |
| Abbott Laboratories | $388.24 | 4 | $0 (2024) |
| Medtronic Vascular, Inc. | $265.13 | 5 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $238.57 | 7 | $0 (2024) |
| iRhythm Technologies, Inc. | $196.82 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $149.59 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $125.94 | 6 | $0 (2024) |
| PFIZER INC. | $61.23 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $44.01 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $628.79 | 19 | E.R. Squibb & Sons, L.L.C. ($203.33) |
| 2023 | $462.39 | 9 | iRhythm Technologies, Inc. ($196.82) |
| 2022 | $19.22 | 1 | E.R. Squibb & Sons, L.L.C. ($19.22) |
| 2021 | $118.64 | 1 | Abbott Laboratories ($118.64) |
| 2020 | $113.57 | 1 | Boston Scientific Corporation ($113.57) |
| 2019 | $218.40 | 2 | Boston Scientific Corporation ($125.00) |
| 2018 | $644.04 | 10 | Medtronic Vascular, Inc. ($265.13) |
| 2017 | $235.80 | 2 | BOSTON SCIENTIFIC CORPORATION ($125.00) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Cardiovascular | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.03 | General |
| Category: Cardiovascular | ||||||
| 12/03/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.05 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $135.00 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.34 | General |
| Category: Cardiovascular | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $141.86 | General |
| 08/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: DIABETES | ||||||
| 08/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/31/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/24/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $31.06 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/14/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.73 | General |
| 12/06/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/26/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $30.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $166.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2023 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $130.73 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/23/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 3,283 | 4,185 | $808,748 | $166,447 |
| 2022 | 17 | 2,045 | 2,567 | $652,840 | $139,354 |
| 2021 | 16 | 2,539 | 3,471 | $844,509 | $208,935 |
| 2020 | 15 | 2,187 | 2,885 | $587,909 | $140,035 |
Total Patients
10,054
Total Services
13,108
Medicare Billing
$654,772
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 317 | 591 | $312,705 | $63,511 | 20.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 511 | 530 | $153,931 | $30,950 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 107 | 107 | $74,561 | $15,661 | 21.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,449 | 1,896 | $64,710 | $13,655 | 21.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 65 | 67 | $55,356 | $10,638 | 19.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 63 | 117 | $34,624 | $8,651 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 82 | $30,842 | $6,225 | 20.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 360 | 443 | $27,229 | $5,537 | 20.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 42 | 42 | $14,197 | $2,798 | 19.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $8,897 | $2,029 | 22.8% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 23 | 23 | $6,497 | $1,409 | 21.7% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 15 | 15 | $6,531 | $1,376 | 21.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $6,162 | $1,286 | 20.9% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 74 | 74 | $5,344 | $1,124 | 21.0% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 42 | 44 | $4,099 | $933.24 | 22.8% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 22 | 23 | $1,082 | $247.94 | 22.9% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 90 | 90 | $1,099 | $229.62 | 20.9% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 16 | 16 | $881.84 | $185.88 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 309 | 550 | $293,452 | $60,729 | 20.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 351 | 357 | $101,113 | $22,099 | 21.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 56 | $46,268 | $10,358 | 22.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $41,826 | $9,215 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 99 | $37,636 | $7,724 | 20.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 65 | 95 | $28,113 | $6,293 | 22.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 316 | 406 | $25,143 | $5,278 | 21.0% |
About Dr. Douglas Hart, MD
Dr. Douglas Hart, MD is a Cardiovascular Disease healthcare provider based in Yonkers, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801808878.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Hart, MD has received a total of $2,441 in payments from pharmaceutical and medical device companies, with $628.79 received in 2024. These payments were reported across 45 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,441).
As a Medicare-enrolled provider, Hart has provided services to 10,054 Medicare beneficiaries, totaling 13,108 services with total Medicare billing of $654,772. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Yonkers, NY
- Active Since 08/11/2006
- Last Updated 08/21/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1801808878
Products in Payments
- WATCHMAN (Device) $238.57
- CAMZYOS (Drug) $203.33
- ZIO XT Patch (Device) $196.82
- Amplia MRI (Device) $145.30
- AVEIR (Device) $130.73
- WATCHMAN DEVICE (Device) $125.00
- Fortify Assura, Ellipse ICD (Device) $118.64
- Mitra Clip system (Device) $114.78
- LEQVIO (Drug) $114.33
- FARXIGA (Drug) $88.73
- Affinity Fusion (Device) $85.45
- ELIQUIS (Drug) $52.87
- JARDIANCE (Drug) $44.01
- VYNDAQEL (Drug) $43.60
- ENTRESTO (Drug) $35.26
- WATCHMAN FLX (Device) $31.06
- JOT DX (Device) $24.09
- Bio-Console (Device) $17.84
- BRILINTA (Drug) $17.48
- Reveal LINQ (Device) $16.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Yonkers
Sachin Kumar Amruthlal Jain, M.d, M.D
Cardiovascular Disease — Payments: $19,903
Cardiovascular Disease $19,903
Sang Kim, M.d, M.D
Cardiovascular Disease — Payments: $8,929
Cardiovascular Disease $8,929
Slawomir Malendowicz, Md, MD
Cardiovascular Disease — Payments: $2,431
Cardiovascular Disease $2,431
Dr. Gregory Neufeld, M.d, M.D
Cardiovascular Disease — Payments: $2,046
Cardiovascular Disease $2,046
Richard Feldman, M.d, M.D
Cardiovascular Disease — Payments: $1,926
Cardiovascular Disease $1,926
Shahid Sheikh, M.d, M.D
Cardiovascular Disease — Payments: $1,178
Cardiovascular Disease $1,178